RxDoctor Payments Data

Robert Clemency Iii

Foot & Ankle Surgery · Schererville, INNPI 1508127663

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 91.7% of it on its own, with 12 other manufacturers making up the rest. Among foot & ankle surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$215,231in general payments, 2019–2025

Across 339 payments — averaging $634.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$197K
  • Smith+Nephew$17K
  • Integra Lifesciences Corporation$424
  • Stryker$345
  • Orthofix Medical, Inc.$82
  • Polarityte, Inc.$28
  • plus $132 from 7 others

What the payments were for

  • Consulting fees$67,43031%
  • Speaking & faculty fees$117,86855%
  • Travel & lodging$22,29210%
  • Food & beverage$7,6424%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$215,231 in reported general payments places this provider in the 95th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$235,857
Medicare patients
417
Services billed
4,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen49$165
Doxycycline Hyclate20$137
Clindamycin Hcl11$102
Cephalexin29$102
Methylprednisolone20$100
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$84
Ciprofloxacin Hcl23$84
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$45

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Schererville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →